Skip to Main Content

Paper Details

A phase two study of high dose blinatumomab in Richter's syndrome.
Leukemia
11
2022
Author NameAffiliation
Ken ChenThe University of Texas M.D. Anderson Cancer Center
Christine B PetersonThe University of Texas M.D. Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2